Effect of natriuretic peptide family on the oxidized LDL-induced migration of human coronary artery smooth muscle cells

Circulation Research

Volumn 81, Issue 4, 1997, Pages 585-590

  Kohno, Masakazu ^a   Yokokawa, Koji ^b   Yasunari, Kenichi ^b   Kano, Hiroaki ^b   Minami, Mieko ^b   Ueda, Makiko ^b   Yoshikawa, Junichi ^b  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

Human coronary artery; Migration; Natriuretic peptide; Oxidized low density lipoprotein; Smooth muscle cell

Indexed keywords

8 BROMO CYCLIC GMP; CNP 22; CYCLIC GMP; GUANYLATE CYCLASE; LOW DENSITY LIPOPROTEIN; NATRIURETIC PEPTIDE TYPE C; NITROPRUSSIDE SODIUM; UNCLASSIFIED DRUG;

ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CELL MIGRATION; CHEMOTAXIS; CONCENTRATION RESPONSE; CORONARY ARTERY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERCHOLESTEROLEMIA; OXIDATION; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER;

EID: 0030873837     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.81.4.585     Document Type: Article

References (39)

1. Castelli WP, Anderson K. A population at risk: prevalence of high cholesterol levels in hypertensive patients in the Framingham study. Am J Med 1986;80(suppl 2A):23-32.
2. Martin MJ, Hulley SB, Browner WS, Kuller LH, Wentworth D. Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361 662 men. Lancet. 1986;2:933-936.
3. McGill HC Jr, Carey KD, McMahan CA, Marinez YN, Cooper TE, Mott GE, Schwartz CJ. Effects of two forms of hypertension on atherosclerosis in the hyperlipidemic baboon. Arteriosclerosis. 1985; 5:481493.
4. Bretherton KN, Day AJ, Skinner SL. Hypertension-accelerated atherogenesis in cholesterol-fed rabbits. Atherosclerosis. 1977;27: 79-87.
5. Schwartz SM, Campbell GR, Campbell JH. Replication of smooth muscle cells in vascular disease. Circ Res. 1986;58:427-444.
6. Autio I, Jaakkola O, Solakivi T, Nikkari T. Oxidized low-density lipoprotein is chemotactic for arterial smooth muscle cells in culture. FEBS Lett. 1990;277:247-249.
7. Clowes AW, Schwartz SM. Significance of quiescent smooth muscle migration in the injured rat carotid artery. Circ Res. 1985;56: 139-145.
8. Ross R. The pathogenesis of atherosclerosis-an update. N Engl J Med. 1986;314:488-500.
9. de Bold AJ. Atrial natriuretic factor: a hormone produced by the heart. Science. 1985;230:767-770.
10. Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature. 1988;332:78-81.
11. Minamino N, Aburaya M, Ueda S, Kangawa K, Matsuo H. The presence of brain natriuretic peptide of 12.000 dallons in porcine heart. Biochem Biophys Res Commun. 1988;155:740-746.
12. Sugawara A, Nakao K, Morii N, Sakamoto M, Suda M, Shimokura M, Kiso Y, Kohara M, Yamori Y, Nishimura K, Soneda J, Ban T, Imura H. α-Human atrial natriuretic polypeptide is released from the heart and circulates in the body. Biochem Biophys Res Commun. 1985;129:439-446.
13. Mukoyama M, Nakao K, Saito K, Ogawa Y, Hosoda K, Suga S. Shirakami G, Jougasaki M, Imura H. Human brain natriuretic peptide, a novel cardiac hormone, Lancet. 1990;335:801-802.
14. Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y, Shirakami G, Jougasaki M, Obata K, Yasue H, Kambayashi Y, Inoue K, Imura H. Brain natriuretic peptide as a novel cardiac hormone in humans: evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest. 1990;87:1402-1412.
15. Kohno M, Horio T, Yokokawa K, Murakawa K, Yasunari K, Akioka K, Tahara A, Toda I, Takeuchi K, Kurihara N, Takeda T. Brain natriuretic peptide as a cardiac hormone in essential hypertension. Am J Med. 1992;92:29-34.
16. Sudoh T, Minamino N, Kangawa K, Matsuo H. C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun. 1960;168: 863-870.
17. Stingo AJ, Clavell AL, Heublein DM, Wei CM, Piltelkow MR, Burnett JC Jr. Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma. Am J Physiol. 1992;263:H1318H1321.
18. Suga S, Nakao K, Itoh H, Komatsu Y, Ogawa Y, Hama N, Imura H. Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-β. J Clin Invest. 1992;90:1145-1149.
19. Furuya M, Yoshida M, Hayashi Y, Ohnuma N, Minamino N, Kangawa K, Matsuo H. C-type natriuretic peptide is a growth inhibitor of rat vascular smooth muscle cells. Biochem Biophys Res Commun. 1991;177:927-931.
20. Bernd CS, Leslie DC, Richard AC. Oxidized low density lipoproteins cause contraction and inhibit endothelin-dependent relaxation in the pig coronary artery. J Clin Invest. 1990;86:75-79.
21. Horio T, Kohno M, Yasunari K, Murakawa K, Yokokawa K, Ikeida M, Fukui T, Takeda T. Stimulation of endothelin-1 release by low density and very low density lipoproteins in cultured human endothelial cells. Atherosclerosis. 1993:101:185-190.
22. Yasunari K, Kohno M, Murakawa K, Yokokawa K, Horio T, Takeda T. Phorbol ester and atrial natriuretic peptide receptor response on vascular smooth muscle. Hypertension. 1992;19: 314-319.
23. Koyama N, Harada K, Yamamoto A, Morisaki N, Saito Y, Yoshida S. Purification and characterization of an autocrine migration factor for vascular smooth muscle cells (SMC), SMC-derived migration factor. J Biol Client. 1993;268:13301-13308.
24. Horio T, Kohno M, Kano H, Ikeda M, Yasunari K, Yokokawa K, Minami M, Takeda T. Adrenomedullin as a novel antimigration factor of vascular smooth muscle cells. Circ Res. 1995;77:660-664.
25. Kohno M, Yasunari K, Yokokawa K, Murakawa K, Horio T, Takeda T. Inhibition by atrial and brain natriuretic peptides of endothelin-1 secretion after stimulation with angiotensin II and thrombin of cultured human endothelial cells. J Clin Invest. 1991; 87:1999-2004.
26. Kohno M, Yokokawa K, Horio T, Yasunari K, Murakawa K, Takeda T. Atrial and brain natriuretic peptides inhibit the endothelin-l secretory response to angiotensin II in porcine aorta. Circ Res. 1992;70:241-247.
27. Yokokawa K, Tahara H, Kohno M, Mandal AK, Yanagisawa M, Takeda T. Heparin regulates endothelin production through endothelin-derived nitric oxide in human endothelial cells. J Clin Invest. 1993;92:2080-2085.
28. Wallenstein S, Zucker CL, Fleiss JL. Some statistical methods useful in circulation research. Circ Res. 1980;47:1-9.
29. Ylä-Herttuala S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE, Butler S, Witztum JL, Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest. 1989;84:1086-1095.
30. Juul K, Nielsen LB, Munkholm K, Stender S, Nordestgaard BG. Oxidation of plasma low-density lipoprotein accelerates its accumulation and degradation in the arterial wall in vivo. Circulation. 1996;94:1698-1704.
31. Avogaro P, Bon GB, Cazzolato G. Presence of a modified low, density lipoprotein in humans, Arteriosclerosis. 1988;8:79-87.
32. Hodis HN, Kramsch DM, Avogaro P, Bon GB, Cazzolalo G, Hwang J, Peterson H, Sevanian A. Biochemical and cytotoxic characteristics of an in vivo circulating oxidized low density lipoprotein (LDL). J Lipid Res. 1994;35:669-677.
33. Mukoyama M, Nakao K, Obata K, Jougasaki M, Yoshimura M, Morita E, Hosoda K, Suga S, Ogawa Y, Yasue H, Imura H. Augmented secretion of brain natriuretic peptide in acute myocardial infraction. Biochem Biophys Res Commun. 1991;180:431-436.
34. Suga S, Nakao K, Hosoda K, Mukoyama M, Ogawa Y, Shirakami G, Arai H, Saito Y, Kambayashi Y, Inouye K, Imura H. Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natrturetic peptide and C-type natriuretic peptide. Endocrinology. 1992;130:229-239.
35. Koller KJ, Lowe DG, Bennett GL, Minanino N, Kangawa K, Matsuo H, Goeddel DV. Selective activation of the B-natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science. 1991;252:120-213.
36. Suga S, Nakao K, Kishimoto I, Hosoda K, Mukoyama M, Arai H, Shirakami G, Ogawa Y, Komatsu Y, Nakagawa O, Hama N, Imura H. Phenotype-related alteration in expression of natriuretic peptide receptors in aortic smooth muscle cells. Circ Res. 1992;71:34-39.
37. Sugiyama S, Kugiyama K, Matsumura T, Suga S, Itoh H, Nakao K, Yasue H. Lipoproteins regulate C-type natriuretic peptide secretion from cultured vascular endothelial cells. Arterioscler Thromb Vasc Biol. 1995;15:1968-1974.
38. Naruko T, Ueda M, van der Wal AC, van der Loos CM, Itoh H, Nakao K, Becker AE. C-type natriuretic peptide in human coronary atherosclerotic lesions. Circulation. 1996;94:3103-3108.
39. Dubey RK, Jackson EK, Lüuscher TF. Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell. J Clin invest. 1945;96:141-149.